<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药闻社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-17T23:12:08+08:00</updated>
  <subtitle>《药闻社》以重磅深度调查报道的形式，为投资者深度剖析具体企业的投资价值与风险，为产业资本与金融资本的融合提供最透明的信息依据。左手医药健康，右手资本市场，大健康产业第一深度新媒体。不定期更新，只发重磅。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>应收账款占比营收超六成 嘉和美康赊销“凶猛”</title>
    <updated>2020-11-17T22:19:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/QzZDGvSm1NTLW0ZKyhvD9g</id>
    <link href="https://mp.weixin.qq.com/s/QzZDGvSm1NTLW0ZKyhvD9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>麦默真空完成B轮数千万元融资；​至善医疗完成数千万元B轮融资</title>
    <updated>2020-11-17T22:19:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/0ZZaocO7Yx-ew_AaKZIUxg</id>
    <link href="https://mp.weixin.qq.com/s/0ZZaocO7Yx-ew_AaKZIUxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判：中国特色“医保”悬崖！</title>
    <updated>2020-11-16T19:22:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/eWDkf-PMYrP_aWojqucThA</id>
    <link href="https://mp.weixin.qq.com/s/eWDkf-PMYrP_aWojqucThA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中生康元完成数千万A轮融资；汇医慧影完成C2轮数亿元融资</title>
    <updated>2020-11-16T19:22:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Rr6G3IzFjqjqL9pJEAZEyg</id>
    <link href="https://mp.weixin.qq.com/s/Rr6G3IzFjqjqL9pJEAZEyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>细胞免疫疗法：盛名之下，其实难副？</title>
    <updated>2020-11-15T19:25:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/TFKSEK1JbFmHAlalHUIaCQ</id>
    <link href="https://mp.weixin.qq.com/s/TFKSEK1JbFmHAlalHUIaCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>疫苗上市公司哪家强？浅析疫苗大品种时代的投资价值！</title>
    <updated>2020-11-14T19:37:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/MDLFSC0I57CsRXXCyklzxA</id>
    <link href="https://mp.weixin.qq.com/s/MDLFSC0I57CsRXXCyklzxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>后疫情时代：手握监护仪现金奶牛，宝莱特更钟情千亿血透？</title>
    <updated>2020-11-13T01:33:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/MEBYGhdd9Rf4Or7o4FOdPA</id>
    <link href="https://mp.weixin.qq.com/s/MEBYGhdd9Rf4Or7o4FOdPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球领先的3D打印药物技术公司三迭纪完成近亿元A+轮融资</title>
    <updated>2020-11-13T01:33:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/2m7i5BsbVRO4VMzaA7Z6_A</id>
    <link href="https://mp.weixin.qq.com/s/2m7i5BsbVRO4VMzaA7Z6_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>掘金IVD潜力赛道  41家创投逐鹿77亿POCT市场</title>
    <updated>2020-11-11T22:05:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/ush66QNn4yaP-stYne5fkw</id>
    <link href="https://mp.weixin.qq.com/s/ush66QNn4yaP-stYne5fkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚虹医药宣布完成7亿元D轮融资；厚凯医疗完成超亿元人民币C轮融资</title>
    <updated>2020-11-11T22:05:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/o46mjEqhw-kEj5PSwHX5xw</id>
    <link href="https://mp.weixin.qq.com/s/o46mjEqhw-kEj5PSwHX5xw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞新冠疫苗带崩医疗板块？中国疫苗研发紧随其后</title>
    <updated>2020-11-10T22:31:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/ZPm2d7gCRt5d1VPuvjn1cQ</id>
    <link href="https://mp.weixin.qq.com/s/ZPm2d7gCRt5d1VPuvjn1cQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科亚方舟完成C轮2亿+融资</title>
    <updated>2020-11-10T22:31:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/cMFOVLwyB8PLNjwlHjR03Q</id>
    <link href="https://mp.weixin.qq.com/s/cMFOVLwyB8PLNjwlHjR03Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>紧握多个原料药全球话语权 普洛药业CDMO业务增长强劲</title>
    <updated>2020-11-09T21:45:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/81vCwC6LrWk2SeGC43j6vg</id>
    <link href="https://mp.weixin.qq.com/s/81vCwC6LrWk2SeGC43j6vg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>价值研判！未来2-3年，这6只医药股或冲上千亿市值！</title>
    <updated>2020-11-08T21:43:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/5XZallqyDadC66APa4-pMQ</id>
    <link href="https://mp.weixin.qq.com/s/5XZallqyDadC66APa4-pMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>错杀便是机会！千亿规模的IVD行业会被集采吗？</title>
    <updated>2020-11-07T22:06:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/Nqavtd185WVIY6oezVvQHA</id>
    <link href="https://mp.weixin.qq.com/s/Nqavtd185WVIY6oezVvQHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>